Clinical, anatomopathological and molecular characteristics of colorectal cancer by tumor location and degree of differentiation

Authors

  • Laura Vilorio-Marqués Universidad de León
  • Antonio José Molina Universidad de León
  • Cristina Diez Tascón Complejo Asistencial Universitario de León
  • Begoña Álvarez Cuenllas Complejo Asistencial Universitario de León
  • Concepción Álvarez Cañas Complejo Asistencial Universitario de León
  • Mercedes Hernando Martín Complejo Asistencial Universitario de León
  • Tania Fernández Villa Universidad de León
  • Tomás Elosua Complejo Asistencial Universitario de León
  • Vicente Martín CIBERESP

Keywords:

Colorectal neoplasms, Neoplasm grading, Neoplasm staging, Neoplasms by location, Biological markers

Abstract

Aims: Colorectal cancer (CRC) has a high incidence and mortality, with different pat- terns depending on anatomical location and other pathological characteristics that appear linked to changes in exposure risk factors exposure as well as the diagnosis. All these make it essential to determine the source of the tumour to properly assess the effect of these factors in the development, diagnosis and progression of the disease. The aim was to describe the clinical and anatomical-pathological characteristics of patients diagnosed with CRC in the Health Area of Leon (A5L) based on their location and degree of tumour differentiation.
Methods: Information was collected on the clinical and pathological characteristics, including biological markers analysed in clinical routine of 408 patients between 25 and 85 years with a confirmed diagnosis of CRC, and residents in ASL at least six months before diagnosis. Univariate and bivariate analyses were performed according to the degree of differentiation and tumour location.
Results: Tumour size decreases from the colon to the rectum from location decline proximal colon to the rectum (Proximal Colon=5.13cm; Distal Colon=4.09cm; Rectum=3.17cm, P< 0.001), with the TNM stage also being higher in proximal areas. Mucinous adenocarcinomas are more frequent in poorly differentiated than in well differentiated tumours (23.1% vs 5.5%). Lymphatic, venous and peri-tumour invasions are more common in poorly differentiated tumours.
Conclusions: The distribution in accordance with the location has more advanced TNM stages in the proximal areas, which could be related to the poorer early diagnosis in proximal areas. The association between venous and lymphatic invasion with the degree of differentiation is poorly understood, and requires studies to clarify their possible prognostic interest.

Author Biographies

Laura Vilorio-Marqués, Universidad de León

Grupo de Investigación en Interacción Gen-Ambiente-Salud, Universidad de León, León, España

Antonio José Molina, Universidad de León

Grupo de Investigación en Interacción Gen-Ambiente-Salud, Universidad de León, León, España

Cristina Diez Tascón, Complejo Asistencial Universitario de León

Servicio de Anatomía Patológica, Complejo Asistencial Universitario de León (CAULE), León, España

Begoña Álvarez Cuenllas, Complejo Asistencial Universitario de León

Servicio de Digestivo, Complejo Asistencial Universitario de León, León, España

Concepción Álvarez Cañas, Complejo Asistencial Universitario de León

Servicio de Anatomía Patológica, Complejo Asistencial Universitario de León (CAULE), León, España

Mercedes Hernando Martín, Complejo Asistencial Universitario de León

Servicio de Anatomía Patológica, Complejo Asistencial Universitario de León (CAULE), León, España

Tania Fernández Villa, Universidad de León

Grupo de Investigación en Interacción Gen-Ambiente-Salud, Universidad de León, León, España

Tomás Elosua, Complejo Asistencial Universitario de León

Servicio de Cirugía, Complejo Asistencial Universitario de León (CAULE), León, España

Vicente Martín, CIBERESP

Centro de Investigación Biomédica en Red Epidemiología y Salud Pública, CIBERESP, Madrid, España

References

International Agency for Research on Cancer. World Cancer Report 2008. Lyon: IARC; 2008.

López-Abente G, Ardanaz E, Torrella-Ramos A, Mateos A, Delgado-Sanz C, Chirlaque MD, et al. Changes in colorectal cancer incidence and mortality trends in Spain. Ann Oncol. 2010;21 Suppl 3:iii76-82.

https://doi.org/10.1093/annonc/mdq091

Naveiro JC, Peral A, Diez AE, González FA, Burón JL. Incidencia y riesgo de cáncer en el área sanitaria de León. Oncología. 2001;24:21-8.

Martín Sánchez V, Muinelo Voces MI, Jorquera Plaza F, Molina De La Torre AJ, De Abajo Olea S, Tamames Gómez S, et al. Tendencia y distribución municipal de la incidencia de cáncer colorrectal en el área de salud de León (1994-2008). Gastroenterol Flepatol. 2012;35(5):299-308.

https://doi.org/10.1016/j.gastrohep.2012.01.004

Chauvenet M, Cottet V, Lepage C, Jooste V, Faivre J, Bouvier AM. Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population. BMC Cancer. 2011;11:282.

https://doi.org/10.1186/1471-2407-11-282

Flemminki K, Santi I, Weires M, Thomsen H, Sundquist J, Bermejo JL. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer. 2010;10:688.

https://doi.org/10.1186/1471-2407-10-688

Kaemmerer E, Klaus C, Jeon MK, Gassier N. Molecular classification of colorectal carcinomas: the genotype-to-phenotype relation. World J Gastroenterol. 2013;19(45):8163-7.

https://doi.org/10.3748/wjg.v19.i45.8163

Sobin LH. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol. 2003;21(1):3-7.

https://doi.org/10.1002/ssu.10014

Carmona FJ, Esteller M. Epigenomics of human colon cancer. Mutat Res. 2010;693:53-60.

https://doi.org/10.1016/j.mrfmmm.2010.07.007

Perea J, Lomas M, Hidalgo M. Molecular basis of colorrectal cancer: towards an individualized management? Rev Esp Enferm Dig. 2011; 103(1 ):29-35.

https://doi.org/10.4321/S1130-01082011000100006

AJCC: Colon and rectum.Edge SB, Byrd DR, Compton CC, editores. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. p. 143-64.

https://doi.org/10.1007/978-0-387-88441-7_14

Minoo P, Zlobec I, Peterson M, Terraciano L, Lugli A. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol. 2010;37(3):707-18.

https://doi.org/10.3892/ijo_00000720

Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut. 2011;60(3):397-411.

https://doi.org/10.1136/gut.2010.217182

Caldarella A, Crocetti E, Messerini L, Paci E. Trends in colorectal incidence by anatomic subsite from 1985 to 2005: a population- based study. Int J Colorectal Dis. 2013;28(5):637-41.

https://doi.org/10.1007/s00384-013-1672-2

Thelwell N, Millington S, Solinas A, Booth J, Brown T. Mode of action and application of Scorpion primers to mutation detection. Nucleic Acids Res. 2000;28(19):3752-61.

https://doi.org/10.1093/nar/28.19.3752

Whitcombe D, Theaker J, Guy SP, Brown T, Little S. Detection of PCR products using self-probing amplicons and fluorescence. Nat Biotechnol. 1999;17(8):804-7.

https://doi.org/10.1038/11751

Zlobec I, Baker K, Minoo P, Hayashi S, Terracciano L, Lugli A. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups. Cancer. 2009;115(17):4021-9.

https://doi.org/10.1002/cncr.24450

Krzystek-Korpacka M, Diakowska D, Grabowski K, Gamian A. Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study. Int J Colorectal Dis. 2012;27(10):1319-24.

https://doi.org/10.1007/s00384-012-1476-9

Zlobec I, Bihl M, Schwarb H, Terracciano L, Lugli A. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis. Int J Cancer. 2010;127(2):367-80.

https://doi.org/10.1002/ijc.25042

Song W, Wu SJ, He YL, Cai SR, Zhang CH, Zhang XH, et al. Clinicopathological features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern china. Chin Med. 2009; 122(13): 1486-91.

Purim O, Gordon N, Brenner B. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome. Med Sci Monit. 2013;19:203-9.

https://doi.org/10.12659/MSM.883842

Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer. 2007;96(5):828-31.

https://doi.org/10.1038/sj.bjc.6603628

Jacobs ET, Thompson PA, Martinez ME:. Diet, gender, and colorectal neoplasia. J Clin Gastroenterol. 2007;41(8):731-46.

https://doi.org/10.1097/MCG.0b013e3180338e56

Koo JH, Leong RW. Sex differences in epidemiological, clinical and pathological characteristics of colorectal cancer. J Gastroenterol Hepatol. 2010;25(1):33-42.

https://doi.org/10.1111/j.1440-1746.2009.05992.x

Chiang JM, Yeh CY, Changchien CR, Chen JS, Tang R, Chen JR. Mucinous adenocarcinoma showing different clinicopathological features and molecular characteristics in relation to different colorectal cancer subgroups. Int J Colorectal Dis. 2010;25(8):941-7.

https://doi.org/10.1007/s00384-010-0958-x

Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nis- hihara R, et al. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut. 2012;61(6):847-54.

https://doi.org/10.1136/gutjnl-2011-300865

Verhulst J, Ferdinande L, Demetter P, Ceelen W. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012;65(5):381-8.

https://doi.org/10.1136/jclinpath-2011-200340

Derwinger K, Gustavsson B. A study of aspects on gender and prognosis in synchronous colorectal cancer. Clin Med Insights Oncol. 2011;5:259-64.

https://doi.org/10.4137/CMO.S7871

Du CZ, Xue WC, Cai Y, Li M, Gu J. Lymphovascular invasion in rectal cancer following neoadjuvant radiotherapy: a retrospective cohort study. World J Gastroenterol. 2009;15(30):3793-8.

https://doi.org/10.3748/wjg.15.3793

Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, laco- petta BJ, et al. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer. 2001;85(5):692-6.

https://doi.org/10.1054/bjoc.2001.1964

Jenkins AAA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007;133(1):48-56.

https://doi.org/10.1053/j.gastro.2007.04.044

Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, Edwards S, et al. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum. 2009;52(7):1304-11.

https://doi.org/10.1007/DCR.0b013e3181a0e5df

How to Cite

[1]
Vilorio-Marqués L. et al. 2015. Clinical, anatomopathological and molecular characteristics of colorectal cancer by tumor location and degree of differentiation. Revista Colombiana de Cancerología. 19, 4 (Dec. 2015), 193–203.

Downloads

Download data is not yet available.

Published

2015-12-01

Issue

Section

Research/original articles